making accurate, valuable information accessible
Well, frankly, not much.
Medical education (med ed) agencies are virtually the same as medical communications agencies, and at Rx Communications we call ourselves by either term. Some med ed agencies focus on delivering marketing & training materials that help pharmaceutical and medical devices companies educate patients, subscribers and payers not only about their product but also about disease awareness. Other medical communications agencies may concentrate on developing the scientific platform for key opinion leaders (KOLs), which would include scientific and clinical journal publications as well as congress materials. Yet others may focus on clinical trial documents and regulatory materials. With our range of writer expertise and superb project management, we can manage it all. We deliver quality clinical and pre-clinical study protocols, reports and investigator materials, alongside medical communications and medical education in whatever format our clients want.
Our only criterion is that the project in question has a valid scientific foundation so that whatever we do adds to an evidence base that supports and encourages good healthcare information and decision-making.
EBM or evidence-based medicine is vital for improving healthcare. And so much of it now incorporates the use of big data and outcomes research. The sheer volume of data can make the job of communication a tricky one – data selection is vital but must not bias the evidence. This is where publications planning and communications strategy comes in.
Initially, the focus should be on understanding how, when and why healthcare decisions are made – and of course, who makes them. By healthcare decisions we mean decisions right from the top, e.g. government policy, regulatory authorities, formulary committees etc. right down to the selection of a particular wound covering made by a nurse, a prescription by a subscriber, or an OTC (over the counter) healthcare product decision made by a patient/consumer.
A medical communications agency worth its salt should help find the answers to these questions, take the evidence available, perform the necessary competitor and benchmarking analyses and be able to come up with a publications plan and/or communications strategy that fulfils these criteria for the decisionmakers that are most important to the client.
Of course, to collect ALL the evidence necessary to fulfil every audience/decisionmaker in every country is an impossible task. And hugely expensive. So the next questions become: Who are the most important target audiences, and when, how and what do they need to know/understand to make healthcare decisions?
Sadly, the confidential nature of our work means that our client testimonials are anonymous, but we still think it’s important for you to know what they think of us anyway!
Center for Medicare and Medicaid Innovation (CMMI) Director Elizabeth Fowler recently discussed Biogen’s Aduhelm drug. She noted that Congress first needs to make a decision regarding drug pricing […]
Lark Health has announced $100 million in series D funding. The disease management startup uses artificial intelligence (AI) and healthcare analytics to reduce healthcare costs associated with […]
Vice President of Business Development & Real World Evidence (RWE) at ArborMetrix Benjamin Echeazu discusses the growing use of RWE in a wide range of applications—from drug development to […]
Viruses and bacteria such as Streptococcus pneumoniae, Haemophilus influenzae type B and respiratory syncytial virus (RSV) are common causes of pneumonia. Pneumonia is also a complication of SARS-CoV-2 (COVID-19). Ongoing…
Effective public health communication strategies are essential to educate public audiences about the important health issues facing their community. Whether it is an emergency, such as we have seen with…
Every year, one in five Americans will experience some form of mental illness. It could be a friend, a family member, a work colleague – or even you, and while…
Last year, 2.3 million women worldwide were diagnosed with breast cancer. Thankfully, when diagnosed early, breast cancer survival rates are greater than 90%. Modifiable risk factors, such as smoking, exercise…
Alzheimer’s disease is the most common cause of dementia; about 60–80% of people with dementia have Alzheimer’s. In high-income countries, Alzheimer’s disease and other dementias are the second leading cause…
If you need to write a scientific conference report, it’s probably not just for fun. It might be for a client who has an interest in a particular therapeutic area,…
Get our Health Outcomes Communicator direct to your inbox – sign-up now!
Please note: we will not pass your details on to any third-parties. View our Privacy Policy here.
